Clinical trial
Intermittent Hypoxia and Caffeine in Infants Born Preterm (ICAF)
NCT03321734 is registered in ClinicalTrials.gov with Children's National Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intermittent Hypoxia and Caffeine in Infants Born Preterm (ICAF)
- Lead sponsor
- Children's National Research Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 18, 2019
- Completion date
- June 1, 2023
- Enrollment
- 170 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
intermittent hypoxia